Advertisement

Thyroid hormone resistance from newborns to adults: a Spanish experience

  • A. Vela
  • G. Pérez-Nanclares
  • I. Ríos
  • I. Rica
  • N. Portillo
  • L. CastañoEmail author
  • Spanish Group for the Study of RTH
Original Article
  • 14 Downloads

Abstract

Objective

Thyroid hormone resistance (RTH β) is a rare genetic disorder characterized by an altered response of target tissue to the action of thyroid hormone. Few studies on RTH β have been carried out in southern European populations. We aimed to describe the clinical and genetic characteristics at the time of diagnosis in a Spanish cohort of patients with genetically confirmed RTH β, with ages ranging from newborns to adults.

Methods

Retrospective multicenter study of 28 patients who were genetically confirmed as RTH β. Clinical and biochemical data were collected from the reference centers, and the studied variables included age, sex, anthropometric data, clinical characteristics and biochemical results. In the Basque country, a simultaneous analysis of TSH and T4 is carried out in the program for the screening of inborn errors of metabolism. A molecular analysis of the thyroid hormone beta (THRB) gene was performed.

Results

The total cohort included 20 adults and eight pediatric patients (six newborns). Of the total, 5 (17.8%) were diagnosed by clinical characteristics (goiter, hypertension or tachycardia), 13 (46.4%) were analyzed in the context of a family study and 10 (35.7%) were diagnosed after obtaining an altered fT4 and/or TSH level in a biochemical analysis performed due to clinical symptoms unrelated to RTH β. Four of the newborns included in the series were diagnosed by the result of neonatal screening, which allows us to estimate a minimum local incidence of RTH β of 1/18,750 live newborns. The genetic analysis showed the presence of 12 different heterozygous mutations in the THRB gene.

Conclusions

We report the clinical and genetic characteristics of a Spanish RTH β cohort, from neonates to adults. We also describe one novel mutation in the THRB gene as the cause of the disease. The simultaneous analysis of TSH and T4 carried out in the program for the screening of inborn errors of metabolism facilitates the early diagnosis of RTH β in newborns and has allowed us to estimate a minimum local incidence of RTH of 1/18,750 live newborns.

Keywords

Resistance to thyroid hormones THRB gene RTH β management Early diagnosis of RTH β Spanish cohort 

Notes

Acknowledgements

We kindly thank all members of the affected families by their collaborative participation in this study. The authors would like to thank Dr. Pedro Martul for his inestimable efforts in conceiving this project. Members of the Spanish Group for the Study of RTH include the following institutions: Cruces University Hospital (P. Martul, G. Grau, S. Gaztambide, A. Cortázar); BioCruces Health Research Institute (A. Aguayo); Donostia University Hospital (E. Artola, R. Sáez, C. García); Araba University Hospital (MA. Vicente, N. González); Marqués de Valdecilla University Hospital (MC. García, C. Luzuriaga); Asturias Central University Hospital (L. Cacho, C. Sánchez); Jaen Hospital Complex (C. Sánchez); San Agustín Avilés Hospital, CIBERESP (I. Riaño-Galán); Valle del Nalón Hospital (MC. Díaz de Greñu); La Paz University Hospital (B. Lecumberri); Virgen de la Luz Hospital (DM. Calderón); Toledo Hospital Complex (E. Castro); Badajoz University Hospital (P. Beato-Víbora).

Compliance with ethical standards

Conflict of interest

On behalf of all authors, the corresponding author states there is no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Written informed consent has been obtained from all adult patients included in this study. In the case of minors, written informed consent from their guardians was obtained before enrolling them in the study.

References

  1. 1.
    Refetoff S, Bassett JH, Beck-Peccoz P, Bernal J, Brent G, Chatterjee K et al (2014) Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism. Thyroid 24(3):407–409PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    LaFranchi SH, Snyder DB, Sesser DE, Skeels MR, Singh N, Brent GA et al (2003) Follow-up of newborns with elevated screening T4 concentrations. J Pediatr 143(3):296–301PubMedCrossRefGoogle Scholar
  3. 3.
    Refetoff S, DeWind LT, DeGroot LJ (1967) Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab 27(2):279–294PubMedCrossRefGoogle Scholar
  4. 4.
    Beck-Peccoz P, Chatterjee VK (1994) The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 4(2):225–232PubMedCrossRefGoogle Scholar
  5. 5.
    Brucker-Davis F, Skarulis MC, Grace MB, Benichou J, Hauser P, Wiggs E et al (1995) Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health Prospective Study. Ann Intern Med 123(8):572–583Google Scholar
  6. 6.
    Refetoff S, Weiss RE, Usala SJ (1993) The syndromes of resistance to thyroid hormone. Endocr Rev 14(3):348–399PubMedGoogle Scholar
  7. 7.
    Lazar MA (1993) Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev 14(2):184–193PubMedGoogle Scholar
  8. 8.
    Usala SJ, Bale AE, Gesundheit N, Weinberger C, Lash RW, Wondisford FE et al (1988) Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbA beta gene. Mol Endocrinol 2(12):1217–1220PubMedCrossRefGoogle Scholar
  9. 9.
    Refetoff S, Dumitrescu AM (2007) Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract Res Clin Endocrinol Metab 21(2):277–305PubMedCrossRefGoogle Scholar
  10. 10.
    Ferrara AM, Onigata K, Ercan O, Woodhead H, Weiss RE, Refetoff S (2012) Homozygous thyroid hormone receptor β-gene mutations in resistance to thyroid hormone: three new cases and review of the literature. J Clin Endocrinol Metab 97(4):1328–1336PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Yoh SM, Chatterjee VK, Privalsky ML (1997) Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors. Mol Endocrinol 11(4):470–480PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Liu Y, Takeshita A, Misiti S, Chin WW, Yen PM (1998) Lack of coactivator interaction can be a mechanism for dominant negative activity by mutant thyroid hormone receptors. Endocrinology 139(10):4197–4204PubMedCrossRefGoogle Scholar
  13. 13.
    Meier CA, Dickstein BM, Ashizawa K, McClaskey JH, Muchmore P, Ransom SC et al (1992) Variable transcriptional activity and ligand binding of mutant beta 1 3,5,3'-triiodothyronine receptors from four families with generalized resistance to thyroid hormone. Mol Endocrinol 6(2):248–258PubMedGoogle Scholar
  14. 14.
    Anselmo J, Cao D, Karrison T, Weiss RE, Refetoff S (2004) Fetal loss associated with excess thyroid hormone exposure. JAMA 292(6):691–695PubMedCrossRefGoogle Scholar
  15. 15.
    Amor AJ, Halperin I, Alfayate R, Borrás VM, Escribano A, González C et al (2004) Identification of four novel mutations in the thyroid hormone receptor-β gene in 164 Spanish and 2 Greek patients with resistance to thyroid hormone. Hormones (Athens) 13(1):74–78Google Scholar
  16. 16.
    Bottcher Y, Paufler T, Stehr T, Bertschat FL, Paschke R, Koch CA (2007) Thyroid hormone resistance without mutations in thyroid hormone receptor beta. Med Sci Monit 13(6):CS67–CS70Google Scholar
  17. 17.
    Chiesa A, Olcese MC, Papendieck P, Martinez A, Vieites A, Bengolea S et al (2012) Variable clinical presentation and outcome in pediatric patients with resistance to thyroid hormone (RTH). Endocrine 41(1):130–137PubMedCrossRefGoogle Scholar
  18. 18.
    Asteria C, Rajanayagam O, Collingwood TN, Persani L, Romoli R, Mannavola D et al (1999) Prenatal diagnosis of thyroid hormone resistance. J Clin Endocrinol Metab 84(2):405–410PubMedCrossRefGoogle Scholar
  19. 19.
    Dhingra S, Owen PJ, Lazarus JH, Amin P (2008) Resistance to thyroid hormone in pregnancy. Obstet Gynecol 112(2 Pt 2):501–503PubMedCrossRefGoogle Scholar
  20. 20.
    Weiss RE, Dumitrescu A, Refetoff S (2010) Approach to the patient with resistance to thyroid hormone and pregnancy. J Clin Endocrinol Metab 95(7):3094–3102PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Pappa T, Anselmo J, Mamanasiri S, Dumitrescu AM, Wriss RE, Refetoff S (2017) Prenatal diagnosis of resistance to thyroid hormone and its clinical implications. J Clin Endocrinol Metab 102(10):3775–3782PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Beato-Víbora P, Arroyo-Díez J, Rodríguez-López R (2013) Thyroid hormone resistance caused by a novel deleterious variant of the thyroid hormone receptor beta gene. Eur J Obstet Gynecol Reprod Biol 167(1):118–119PubMedCrossRefGoogle Scholar
  23. 23.
    Fukata S, Brent GA, Sugawara M (2005) Resistance to thyroid hormone in Hashimoto's thyroiditis. N Engl J Med 352(5):517–518PubMedCrossRefGoogle Scholar
  24. 24.
    Barkoff MS, Kocherginsky M, Anselmo J, Weiss RE, Refetoff S (2010) Autoimmunity in patients with resistance to thyroid hormone. J Clin Endocrinol Metab 95(7):3189–3193PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Torre P, Bertoli M, Di Giovanni S, Scommegna S, Conte C, Novelli G et al (2005) Endocrine and neuropsychological assessment in a child with a novel mutation of thyroid hormone receptor: response to 12-month triiodothyroacetic acid (TRIAC) therapy. J Endocrinol Invest 28(7):657–662Google Scholar
  26. 26.
    Han R, Ye L, Jiang X, Zhou X, Billon C, Guan W et al (2015) Characteristics of patients with late manifestation of resistance thyroid hormone syndrome: a single-center experience. Endocrine 50:689–697PubMedCrossRefGoogle Scholar
  27. 27.
    Macchia E, Lombardi M, Raffaelli V, Piaggi P, Macchia L, Scattina I et al (2014) Clinical and genetic characteristics of a large monocentric series of patients affected by thyroid hormone (Th) resistance and suggestions for differential diagnosis in patients without mutation of Th receptor β. Clin Endocrinol (Oxf). 81(6):921–928PubMedCrossRefGoogle Scholar
  28. 28.
    Safer JD, Colan SD, Fraser LM, Wondisford FE (2001) A pituitary tumor in a patient with thyroid hormone resistance: a diagnostic dilemma. Thyroid 11(3):281–291PubMedCrossRefGoogle Scholar
  29. 29.
    Tsukaguchi H, Yoshimasa Y, Fujimoto K, Ishii H, Yamamoto T, Yoshimasa T et al (1995) Three novel mutations of thyroid hormone receptor beta gene in unrelated patients with resistance to thyroid hormone: two mutations of the same codon (H435L and H435Q) produce separate subtypes of resistance. J Clin Endocrinol Metab 80(12):3613–3616PubMedCrossRefGoogle Scholar
  30. 30.
    Ho CW, Chan RM, Lim YY, Loke KY, Lee YS (2014) Thyroid hormone resistance due to a novel THRß mutation. Ann Acad Med Singapore 43(4):241–243PubMedGoogle Scholar
  31. 31.
    Nomura Y, Nagaya T, Tsukaguchi H, Takamatsu J, Seo H (1996) Amino acid substitutions of thyroid hormone receptor-beta at codon 435 with resistance to thyroid hormone selectively alter homodimer formation. Endocrinology 137(10):4082–4086PubMedCrossRefGoogle Scholar
  32. 32.
    Işık E, Beck Peccoz P, Campi I, Özön A, Alikaşifoğlu A, Gönç N et al (2013) Thyroid hormone resistance: a novel mutation in thyroid hormone receptor beta (THRB) gene—case report. Turk J Pediatr 55(3):322–327PubMedGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2019

Authors and Affiliations

  • A. Vela
    • 1
  • G. Pérez-Nanclares
    • 1
  • I. Ríos
    • 1
  • I. Rica
    • 1
  • N. Portillo
    • 2
  • L. Castaño
    • 1
    Email author
  • Spanish Group for the Study of RTH
  1. 1.Biocruces Health Research InstituteCruces University Hospital, CIBERER, CIBERDEM, UPV-EHUBarakaldoSpain
  2. 2.Biocruces Health Research InstituteAlto Deba HospitalGipuzkoaSpain

Personalised recommendations